News Release

Change of the Name of Kirin Kunpeng (China) Bio-Pharmaceutical Co., Ltd.

April 26, 2012

Tokyo, Japan, April 26, 2012 --- "Kirin Kunpeng (China) Bio-Pharmaceutical Co., Ltd.," a subsidiary of Kyowa Hakko Kirin Co., Ltd., ("Kyowa Hakko Kirin") and engaged in developing, manufacturing, and selling ethical drugs in China, changed its name to "Kyowa Hakko Kirin China Pharmaceutical Co., Ltd.," effective April 23, 2012.

Reason for the change

Kyowa Hakko Kirin took full ownership of Kirin Kunpeng (China) Bio-Pharmaceutical Co., Ltd., as a fully owned subsidiary in 2010.

You can see this table by scrolling horizontally.

Outline of Kyowa Hakko Kirin China Pharmaceutical Co., Ltd.
Established June 26, 1997
Located 970 Long Dong Road, Z. J. High-Tech Park, Pudong New Area, Shanghai, China 201203
General Manager Toshihiro Onodera
Capital 29.8 million U.S. dollars
Shareholder Kyowa Hakko Kirin Co., Ltd. (100%)
Sales 230 million CNY (2011)
Business Areas Development, manufacturing, and sale of ethical drugs in China
Main Office Head office, factory: Shanghai
Office: Beijing, Guangzhou, Hangzhou, Chengdu, Hefei
Return to News Releases